Real-Time Oncology Review Speeds Supplements At US FDA, But Gives Modest Benefit For Novel Agents

 
• By Bridget Silverman
Fast Stream
RTOR has produced a steady stream of fast approvals. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers